Please login to the form below

Not currently logged in

10 ways to optimise patient access through the product life cycle with Managed Access Programmes

10 Ways digital opinion leaders

Demand for access to innovative medicines can start building well before drug approval and may continue right through to discontinuation of a product line.

So enabling and maintaining access for patients indeed should be a strategic imperative from top management down. Companies should start thinking about Managed Access Programmes (MAPs) as early as possible in the transition from drug development to commercialisation.

Idis, a global leader in MAPs, looks at the best strategies for optimising the product experience and value on all sides.

View: 10 Ways ... to activate digital opinion leaders online

Please note: Some older digital editions may no longer be accessible while we transition to a new digital edition system and app -

COVID-19 Updates and Daily News

Featured jobs


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...